Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Prostate cancer

Lessons from PIVOT lost in media hype

The screening and treating of prostate cancer is a complex and controversial issue, which seems to have inspired much media coverage. We must be careful to ensure the less-newsworthy facts and limitations of high-profile trials, such as PIVOT, are not lost in media hype.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Carlsson, S. et al. Prostate cancer screening: facts, statistics, and interpretation in response to the US Preventive Services Task Force review. J. Clin. Oncol. 30, 2581–2584 (2012).

    Article  PubMed  PubMed Central  Google Scholar 

  2. Wilt, T. J. et al. Radical prostatectomy versus observation for localized prostate cancer. N. Engl. J. Med. 367, 203–213 (2012).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Charlson, M. E., Pompei, P., Ales, K. L. & MacKenzie, C. R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J. Chronic Dis. 40, 373–383 (1987).

    Article  CAS  PubMed  Google Scholar 

  4. Bill-Axelson, A. et al. Radical prostatectomy versus watchful waiting in early prostate cancer. N. Engl. J. Med. 364, 1708–1717 (2011).

    Article  CAS  PubMed  Google Scholar 

  5. Walter, L. C., Bertenthal, D., Lindquist, K. & Konety, B. R. PSA screening among elderly men with limited life expectancies. JAMA 296, 2336–2342 (2006).

    Article  CAS  PubMed  Google Scholar 

  6. Schröder, F. H. et al. Screening for prostate cancer decreases the risk of developing metastatic disease: findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC). Eur. Urol. http://dx.doi.org/10.1016/j.eururo.2012.05.068.

Download references

Author information

Authors and Affiliations

Authors

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Davies, B. Lessons from PIVOT lost in media hype. Nat Rev Urol 9, 548–549 (2012). https://doi.org/10.1038/nrurol.2012.166

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrurol.2012.166

Search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer